Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mir A Ali

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Leukemia & Lymphoma|October 1, 2016
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the bloodAmber Shatzer, Mir A Ali, Mayra Chavez, et al.
Plos One|December 7, 2013
Altered antibody profiles against common infectious agents in chronic diseasePeter D Burbelo, Kathryn H Ching, Caryn G Morse, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2022
Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After VaccinationJeffrey I Cohen, Lesia Dropulic, Kening Wang, et al.
The Journal of the American Osteopathic Association|August 30, 2016
Education and Communication in an Interprofessional Antimicrobial Stewardship ProgramPamela A Foral, Jennifer M Anthone, Christopher J Destache, et al.
The Journal of Infectious Diseases|March 15, 2021
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 VaccineKening Wang, Lesia Dropulic, Joel Bozekowski, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Leukemia & Lymphoma|October 1, 2016
Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the bloodAmber Shatzer, Mir A Ali, Mayra Chavez, et al.
Plos One|December 7, 2013
Altered antibody profiles against common infectious agents in chronic diseasePeter D Burbelo, Kathryn H Ching, Caryn G Morse, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2022
Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After VaccinationJeffrey I Cohen, Lesia Dropulic, Kening Wang, et al.
The Journal of the American Osteopathic Association|August 30, 2016
Education and Communication in an Interprofessional Antimicrobial Stewardship ProgramPamela A Foral, Jennifer M Anthone, Christopher J Destache, et al.
The Journal of Infectious Diseases|March 15, 2021
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 VaccineKening Wang, Lesia Dropulic, Joel Bozekowski, et al.
Pageof 3